Lyvia Skroblin v. Jill Johnston Yoder

CourtCourt of Appeals of Wisconsin
DecidedNovember 7, 2024
Docket2024AP000557
StatusUnpublished

This text of Lyvia Skroblin v. Jill Johnston Yoder (Lyvia Skroblin v. Jill Johnston Yoder) is published on Counsel Stack Legal Research, covering Court of Appeals of Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lyvia Skroblin v. Jill Johnston Yoder, (Wis. Ct. App. 2024).

Opinion

COURT OF APPEALS DECISION NOTICE DATED AND FILED This opinion is subject to further editing. If published, the official version will appear in the bound volume of the Official Reports. November 7, 2024 A party may file with the Supreme Court a Samuel A. Christensen petition to review an adverse decision by the Clerk of Court of Appeals Court of Appeals. See WIS. STAT. § 808.10 and RULE 809.62.

Appeal No. 2024AP557 Cir. Ct. No. 2023SC6198

STATE OF WISCONSIN IN COURT OF APPEALS DISTRICT IV

LYVIA SKROBLIN,

PLAINTIFF-APPELLANT,

V.

JILL JOHNSTON YODER,

DEFENDANT-RESPONDENT.

APPEAL from an order of the circuit court for Dane County: RHONDA L. LANFORD, Judge. Affirm.

¶1 BLANCHARD, J.1 In this small claims action, Lyvia Skroblin has sued Jill Yoder claiming a breach of contract. Their contract called for Yoder to sell a horse to Skroblin and this transaction occurred. But, soon after Yoder

1 This appeal is decided by one judge pursuant to WIS. STAT. § 752.31(2)(a) (2021-22). All references to the Wisconsin Statutes are to the 2021-22 version unless otherwise noted. No. 2024AP557

delivered the horse to Skroblin, it was diagnosed with lameness. Skroblin took the positions at trial that the lameness was possibly due to an unfavorable genetic condition that can result in a disease of the immune system, equine “Immune Mediated Myositis” (“IMM”), and that, at the time of the sale, Yoder expressly warranted that the horse did not have this genetic condition. The circuit court credited evidence to the effect that Yoder was not obligated, in connection with the sale, to have the horse screened for the genetic condition that can result in IMM. The court also found that Yoder did not in fact represent to Skroblin at the time of sale that the horse did not have the genetic condition.

¶2 Skroblin now appeals a judgment of the circuit court dismissing her complaint. Skroblin contends that the court erred by failing to conclude that Yoder breached an express warranty, an implied warranty, or both, that the horse was not fit for its intended use after sale because it was lame, regardless of what caused it be lame.

¶3 To the extent that Skroblin argues on appeal that Yoder breached an implied warranty, I reject that argument on the ground that Skroblin failed to raise the argument in the circuit court in any form, which she needed to do in order to preserve it as a potential basis for reversal on appeal. Skroblin’s theory at trial was exclusively that Yoder breached an express warranty.

¶4 Regarding Skroblin’s express warranty theory, I conclude that she fails to show that relevant factual findings made by the circuit court at trial were either clearly erroneous or not dispositive in resolving this issue against her.

¶5 Based on these two conclusions, I affirm the judgment.

2 No. 2024AP557

BACKGROUND

¶6 Skroblin sued Yoder in October 2023.

¶7 The operative complaint alleges the following. In May 2023, Skroblin went to Yoder’s property to negotiate the purchase of a horse with Yoder. Skroblin was accompanied by a horse trainer, who Skroblin retained to assist her in assessing horses for potential purchase. During negotiations over a particular horse that Skroblin ended up buying, Skroblin asked Yoder if the horse “had any of the genetic diseases that are panel tested,” and Skroblin’s trainer further asked Yoder whether the horse had any of six specific unfavorable genetic conditions. Pertinent here, the six-condition panel of genetic tests included one for a genetic condition that predisposes a horse to have IMM.2 Yoder allegedly responded, “[M]y horses don’t have any of that.” Skroblin believed that Yoder was selling “a sound horse, with no genetic diseases.” Skroblin paid the contract price of $12,000 in full, and the horse was delivered to her possession in June 2023. “Shortly after the horse was delivered, it became ill due to an infection and presented lameness on its four legs.”3 After months of assessments, one test

2 For context, I note the following general, publicly available information, which is generally consistent with testimony given at trial. “Equine immune-mediated myositis (IMM) is a disease occurring in Quarter horses and QH-related breeds that typically causes rapid and severe symmetrical wasting of the topline muscles, often following exposure to or vaccination against respiratory infection by Streptococcus equi…. Among Quarter horses, IMM ... has a strong familial relationship, suggesting that predisposition to this disease has a genetic basis.” University of California Davis–School of Veterinary Medicine, Immune Mediated Myositis (IMM), https://www.vetmed.ucdavis.edu/labs/finno-laboratory/immune-mediated-myositis-imm (last updated April 8, 2019). 3 Although the specific details do not matter to the analysis of any issue in this appeal, for context I note the following. Trial testimony suggested that, after the sale and transfer, the horse could not place significant weight on one of its front legs when it stood. Skroblin testified at trial that, as of that time, she was able to ride the horse, but that it was still “lame” and not “performing the way [Skroblin] intended [the horse] to perform” at the time of the sale.

3 No. 2024AP557

revealed that the horse was “positive for IMM.”4 Skroblin informed Yoder about this test result and Yoder offered to provide Skroblin with a different horse. Specifically, Yoder offered to give Skroblin a horse that was at that time offered to the public for sale at the price of $6,800, in exchange for the horse that Skroblin bought for $12,000.

¶8 I turn now from the allegations in the complaint to the trial de novo that followed proceedings before a court commissioner. The circuit court trial occurred in March 2024. Neither party was represented by counsel. Both parties testified. Also giving testimony were the horse trainer who Skroblin retained, a veterinarian who treated the horse, and another horse trainer called by Yoder.

¶9 Much of the testimony at trial related to what Yoder did or did not say to Skroblin when Skroblin and her trainer negotiated the purchase of the horse with Yoder. Notably, there was a dispute in the witness testimony about whether Yoder represented to Skroblin that the horse did not have the genetic predisposition to IMM.

¶10 Undisputed, however, was the following testimony that Skroblin gave regarding relevant events. Skroblin did not have the horse assessed by a veterinarian (as opposed to the assessment of the horse trainer who accompanied her to the negotiations) before paying the $12,000 and accepting delivery of the horse. Fewer than ten days after the horse was delivered to Skroblin’s possession,

4 This allegation in the complaint is ambiguous. It could mean that the horse was diagnosed with the disease IMM, or it could mean that the horse tested positive for the genetic condition that predisposes a horse to have that disease. As summarized below, the testimony at trial suggested that there was a test showing that the horse had the genetic mutation that predisposes a horse to IMM.

4 No. 2024AP557

it became lame. Over the course of several months, Skroblin sought treatment and testing for the horse from veterinarians in an attempt to obtain a diagnosis of the cause of the lameness, which persisted. There was an eventual test result showing that the horse had the genetic mutation that predisposes a horse to IMM. More than 90 days after delivery of the horse to Skroblin, Skroblin alerted Yoder about this genetic test result and complained of the continued lameness.

¶11 At the same time, the testimony at trial regarding the cause or causes of the horse’s lameness was ambiguous in several respects.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Pettit
492 N.W.2d 633 (Court of Appeals of Wisconsin, 1992)
Wilson v. Tuxen
2008 WI App 94 (Court of Appeals of Wisconsin, 2008)
Schonscheck v. Paccar, Inc.
2003 WI App 79 (Court of Appeals of Wisconsin, 2003)
Schill v. Wisconsin Rapids School District
2010 WI 86 (Wisconsin Supreme Court, 2010)
King v. Moore
291 N.W.2d 304 (Court of Appeals of Wisconsin, 1980)
State v. Kaczmarski
2009 WI App 117 (Court of Appeals of Wisconsin, 2009)
State v. Huebner
2000 WI 59 (Wisconsin Supreme Court, 2000)
State v. Rogers
539 N.W.2d 897 (Court of Appeals of Wisconsin, 1995)
Nauman v. Ullman
78 N.W. 159 (Wisconsin Supreme Court, 1899)
Townsend v. Massey
2011 WI App 160 (Court of Appeals of Wisconsin, 2011)
State Farm Mutual Automobile Insurance v. Hunt
2014 WI App 115 (Court of Appeals of Wisconsin, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Lyvia Skroblin v. Jill Johnston Yoder, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lyvia-skroblin-v-jill-johnston-yoder-wisctapp-2024.